Clinical Trial Update: Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating a combination therapy of autologous dendritic cells pulsed with antigen peptides plus nivolumab in advanced non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• autologous dendritic cells pulsed with antigen peptides
• nivolumab (nivolumab)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: NSCLC | Phase 1, Phase 2 | Status: UNKNOWN